Skip to main content
Clinical Trials/NCT01734434
NCT01734434CompletedNot Applicable

A Multicenter, Observational Study to Identify Factors That Influence Access of Pregnant Women and Their Infants to Their Local Healthcare Systems

Novartis Vaccines10 sites in 4 countries3,243 target enrollmentStarted: November 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
3,243
Locations
10
Primary Endpoint
Percentage of Subjects Delivering at a Non-study Site.

Study Overview

Brief Summary

This study collected information regarding the factors that might influence access of pregnant women to the local healthcare system. The main visits of the study screened & enrollment, delivery and 90 day infant follow-up. Data were collected mainly from questionnaires administered to pregnant women at these visits. The questionnaires contained the following standard questions which were asked at each visit, in addition to some visit-specific questions related to delivery and health status of infants up to 90 days of age. The standard questions related to the following aspects:

  • Logistics of transportation to the study site (type, time it takes, cost incurred)
  • Accessibility to a telephone/cell phone
  • Provisions of alternative child care during site visits if there are other children under the subject's care

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pregnant women with gestational age of greater than or equal to 24 weeks at the time of enrollment
  • Subject / subject's parents or a legal representative who has given written consent after the nature of the study has been explained according to local regulatory requirements
  • Pregnant women of gestational age between 28 weeks and 34 weeks 6/7 days

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percentage of Subjects Delivering at a Non-study Site.

Time Frame: Baseline until average of 24 weeks

The percentage of subjects who delivered at a non-study site relative to the number of enrolled subjects was calculated.

Percentage of Subjects Delivering at a Study Site.

Time Frame: Baseline until average of 24 weeks

The percentage of subjects who delivered at the study site relative to the number of enrolled subjects was calculated

Secondary Outcomes

  • Number of Infants Brought to Study Site During Infant Follow up (90 Days Post-delivery)(Delivery to Day 90 post-delivery (Infant follow-up))
  • Number of Infants Born Live, Reported Sick and Brought to a Study or Non-study Health Care Facility Site.(Delivery to Day 90 post-delivery (Infant follow-up))

Investigators

Sponsor
Novartis Vaccines
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (10)

Loading locations...

Similar Trials